Publicaciones en colaboración con investigadores/as de Hospital Universitario La Fe (5)

2019

  1. Multicenter retrospective study to evaluate the impact of trabectedin plus pegylated liposomal doxorubicin on the subsequent treatment in women with recurrent, platinum-sensitive ovarian cancer

    Anti-Cancer Drugs, Vol. 30, Núm. 6, pp. 628-635

2018

  1. SEOM clinical guideline on unknown primary cancer (2017)

    Clinical and Translational Oncology, Vol. 20, Núm. 1, pp. 89-96

  2. SEOM clinical guidelines in gestational trophoblastic disease (2017)

    Clinical and Translational Oncology, Vol. 20, Núm. 1, pp. 38-46

2016

  1. SEOM Clinical Guideline in ovarian cancer (2016)

    Clinical and Translational Oncology, Vol. 18, Núm. 12, pp. 1206-1212

2003

  1. Doxorubicin in combination with fluorouracil and cyclophosphamide (i.v. FAC regimen, day 1, 21) versus methotrexate in combination with fluorouracil and cyclophosphamide (i.v. CMF regimen, day 1, 21) as adjuvant chemotherapy for operable breast cancer: A study by the GEICAM group

    Annals of Oncology, Vol. 14, Núm. 6, pp. 833-842